China NMPA Cosmetics Filing & Registration Guide | QuickOEM

Understanding the China NMPA Framework

Every cosmetic product sold in mainland China must clear the National Medical Products Administration (NMPA), the regulator that oversees product safety, efficacy claims and labeling. The legal backbone is the Cosmetic Supervision and Administration Regulation (CSAR), in force since January 2021, supported by a stack of implementing measures on filing, registration, testing and labeling. The system sorts products into two tracks, and picking the wrong one is the single most common reason a launch stalls before it starts.

General Cosmetics Require Filing

The large majority of daily-use products follow the filing pathway. Filing is a notification, not a pre-market approval: the brand uploads a complete dossier to the NMPA online system, and once it is accepted the product may be marketed. Typical general cosmetics include skin care creams, cleansers and lotions, most color cosmetics, shampoos, conditioners, body washes and fragrances. The barrier is preparation quality, not regulator discretion.

Special Cosmetics Require Registration

A defined set of products are treated as special cosmetics and must be registered before sale. Registration is a substantive technical review by NMPA and takes materially longer. The special categories are hair dye, permanent waving, freckle and spot removal with whitening effect, sunscreen, and anti-hair-loss products. Any product claiming a new efficacy not yet catalogued by regulation also enters the registration track. These products carry higher evidence duties because the claimed benefit or risk is greater.

The rule of thumb: if your formula changes skin color, blocks UV, dyes or perms hair, or promises hair growth, plan for registration rather than filing. Everything else is usually filing.

The Responsible Person Requirement

Foreign brands cannot file or register in their own name. China requires a domestic Responsible Person (RP) — a legal entity established in mainland China that holds the product record, receives all regulator correspondence, and is legally accountable for safety and claims. The RP may be your own Chinese subsidiary, a qualified distribution partner, or a specialist compliance agent. Appointing the RP is the first concrete step, because the filing account and every dossier are opened under its name. The RP also owes downstream obligations: it must monitor the market, keep technical documents for inspection, and report adverse reactions.

Required Dossier for NMPA Filing

A complete general-cosmetics filing dossier typically contains the following:

• Product name and naming that follows the Chinese cosmetic naming rules, avoiding medical or exaggerated terms.
• Full INCI ingredient list with concentration ranges, set out in the standardized INCI order.
• Product formula with exact percentages; submitted confidentially to the regulator and never made public.
• Safety assessment report prepared by a qualified assessor and covering every raw material and the finished product.
• Quality and safety control requirements describing specifications, limits and testing methods.
• Product execution standard setting the technical benchmarks each production batch must meet.
• Product testing report from an NMPA-accredited laboratory, required where the rules apply.
• Label and packaging artwork in Chinese, submitted for the record.

Special cosmetics extend the same core set with an efficacy claim basis, supporting efficacy test data, and human safety test reports. When a formula, claim or manufacturer changes after filing, a variation must be submitted rather than silently updated.

Timeline and What to Expect

Filing is quick once the dossier is ready. Acceptance is typically completed within 1 to 5 working days after submission. The real clock starts earlier: budget roughly 4 to 8 weeks to assemble formulas, safety files and any required test reports, and longer if claim-support testing is involved. Registration is a different order of magnitude. A straightforward special-cosmetics file usually takes 3 to 6 months; products needing clinical efficacy or human safety studies can run 9 to 12 months or more. Build the timeline into your launch plan instead of treating it as a formality you handle at the end.

Chinese Labeling Requirements

Labels must be in Simplified Chinese and applied to the product before it reaches the market. A compliant label shows the product name, the Responsible Person name and address, the registered manufacturer, net content, the full ingredient list in INCI and Chinese names, batch number, shelf life or production date, and clear usage and caution statements. Claim language is tightly controlled: wording that implies medical treatment, disease cure, or unproven results is rejected. A barcode and traceability code are expected for retail, and the artwork must match the filed version exactly. Many foreign brands prepare a dedicated Chinese label rather than translating the export one.

The Role of Your China OEM/ODM Factory

A capable OEM/ODM partner does far more than fill and pack. Established Chinese factories already operate inside the NMPA testing and filing workflow, and they supply the formula records, stability data and manufacturing documentation the dossier requires. They can also localize an overseas formula to replace actives that are restricted in China, and they know which accredited labs turn reports around fastest. Through the QuickOEM platform, brands are matched with 500-plus certified factories and can consolidate formulation, testing and filing support in one place, which shortens both preparation and review. The factory cannot serve as your Responsible Person, but it removes most of the technical heavy lifting that causes delays.

Common Pitfalls for Foreign Brands

Foreign teams repeatedly trip on the same issues. Plan around these:

• No domestic Responsible Person. Without one, no filing account exists and nothing can move forward.
• Ingredient not approved in China. Actives legal in the EU or US can be restricted or banned under Chinese rules; screen the formula early.
• Missing or weak safety assessment. A thin or outdated report is the leading rejection reason for filing.
• Label copied from export markets. English-only or medically worded labels fail review and force a costly reprint.
• Wrong pathway. Treating a special cosmetic as a filing wastes months and risks a market ban.
• Last-minute testing. Accredited lab capacity is finite; book testing before you promise a launch date.
• Ignoring post-market duties. The RP must track adverse reactions and keep records ready for inspection after sale.

Compliance is not a tax on speed — it is the speed. Brands that build the dossier alongside formulation launch faster than those that retrofit it after the fact.

With the right Responsible Person, a ready factory, and a dossier started on day one, entering China becomes a managed project rather than a guessing game.